Russell Investments Group’s Korsana Biosciences, Inc. Common Stock KRSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-886
Closed -$345K 3226
2021
Q1
$345K Buy
886
+709
+401% +$53.3K ﹤0.01% 2665
2020
Q4
$75K Sell
177
-191
-52% -$13K ﹤0.01% 2888
2020
Q3
$312K Buy
368
+170
+86% +$19.4K ﹤0.01% 2598
2020
Q2
$163K Buy
198
+25
+14% +$2.09K ﹤0.01% 2772
2020
Q1
$63K Hold
173
﹤0.01% 2839
2019
Q4
$64K Sell
173
-481
-74% -$44.9K ﹤0.01% 2962
2019
Q3
$1.11M Buy
+654
New +$141K ﹤0.01% 1953

Other funds holding KRSA

Russell Investments Group's KRSA Position: Q2 2021 in Review

Russell Investments Group sold out of Korsana Biosciences, Inc. Common Stock (KRSA) in Q2 2021, closing a stake of 886 shares — an estimated $345K sold.

Russell Investments Group first reported a position in KRSA in Q3 2019 and held it in 7 quarters. The position peaked at $1.11M in Q3 2019. 65 funds tracked by Wall St. Rank hold KRSA as of Q2 2021.

  • Russell Investments Group reported no remaining Korsana Biosciences, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Russell Investments Group sold 886 Korsana Biosciences, Inc. Common Stock shares in Q2 2021, an estimated $345K.
  • Russell Investments Group first reported a position in Korsana Biosciences, Inc. Common Stock in Q3 2019 and held it in 7 quarters.
  • Russell Investments Group's Korsana Biosciences, Inc. Common Stock position peaked at $1.11M in Q3 2019.
  • 65 funds tracked by Wall St. Rank held Korsana Biosciences, Inc. Common Stock as of Q2 2021.

Based on Russell Investments Group's 13F filing for Q2 2021, filed 4 Aug 2021.